A UK Biobank cohort conducted on 112,493 people without any cardiometabolic disease and insulin-independent diabetes in the age range of 40–69 years clearly indicated that greater MD compliance was related to decreased probability of diabetes within the UK Biobank. This evidence concerns the gene INS and diabetes mellitus.